H04.143 Primary lacrimal gland atrophy, bilateral lacrimal glands

Name of the Condition

• Primary Lacrimal Gland Atrophy, Bilateral Lacrimal Glands (ICD-10 code: H04.143)

Summary

Primary lacrimal gland atrophy, bilateral lacrimal glands, is a condition involving the progressive degeneration or shrinkage of both lacrimal glands, which are responsible for tear production. This can lead to reduced tear output, resulting in dry eye symptoms or ocular discomfort. The term "primary" indicates the atrophy occurs without an identifiable underlying cause, distinguishing it from secondary atrophy linked to other diseases or trauma.

Causes

The exact cause of primary lacrimal gland atrophy is not fully understood. It is thought to involve age-related changes, autoimmune processes, or degenerative mechanisms affecting the gland tissue. Unlike secondary atrophy, no specific infection, trauma, or systemic disease is identified as the trigger in primary cases.

Risk Factors

Risk factors may include advanced age, as glandular tissue naturally declines over time. Genetic predisposition or a history of autoimmune conditions could also increase susceptibility, though specific associations are not well established for primary cases.

Symptoms

Symptoms typically include persistent dryness, burning, or grittiness in both eyes. Patients may experience reduced tear production, leading to discomfort, redness, or a sensation of foreign bodies. Vision may be temporarily blurred.

Diagnosis

Diagnosis involves a clinical evaluation, including a review of symptoms and a physical examination of the eyes. Tests to assess tear production, such as the Schirmer test, may be performed. Imaging studies or biopsy are rarely needed but could be considered to rule out other conditions.

Treatment Options

Treatment focuses on managing symptoms, such as using artificial tears or lubricating eye drops to relieve dryness. In some cases, anti-inflammatory medications or immunomodulatory therapies may be considered if an autoimmune component is suspected. Regular follow-up with an eye care professional is recommended.

Prognosis and Follow-Up

The prognosis varies depending on the severity of the atrophy and response to treatment. Symptoms can often be managed effectively, but the condition may progress over time. Regular follow-up appointments are important to monitor tear production and adjust treatment as needed.

Complications

Complications may include chronic dry eye, corneal damage, or increased risk of eye infections due to reduced tear film protection. Severe cases could lead to vision impairment if left untreated.

Lifestyle & Prevention

Lifestyle measures to manage symptoms include avoiding dry or windy environments, using a humidifier, and protecting the eyes with sunglasses. Avoiding irritants like smoke or harsh chemicals may also help. There is no known prevention for primary atrophy, but maintaining overall eye health is advisable.

When to Seek Professional Help

Seek medical attention if dry eye symptoms worsen, persist despite treatment, or are accompanied by pain, redness, or vision changes. Early evaluation can help prevent complications and ensure appropriate management.

Tips for Medical Coders

When coding for H04.143, ensure documentation specifies bilateral involvement of the lacrimal glands and confirms the condition is primary (no underlying cause identified). Verify that the diagnosis aligns with clinical findings and that any associated symptoms or treatments are clearly documented to support code assignment.